S/CO ratio | From routine screening | Previous positive cases from serum bank | ||||
Non-treponemal | Treponemal | Primary | Secondary | Early latent | Latent—unknown duration | |
<0.1 | 715 | 0 | 0 | 0 | 0 | 0 |
0.1–0.19 | 294 | 0 | 0 | 0 | 0 | 0 |
0.2–0.29 | 27 | 0 | 0 | 0 | 0 | 0 |
0.3–0.39 | 6 | 0 | 0 | 0 | 0 | 0 |
0.4–0.49 | 3 | 0 | 2 | 0 | 0 | 0 |
0.5–0.59 | 2 | 0 | 0 | 0 | 0 | 0 |
0.6–0.69 | 0 | 0 | 0 | 0 | 0 | 0 |
0.7–0.79 | 1 | 0 | 0 | 0 | 0 | 0 |
0.8–0.89 | 0 | 0 | 0 | 0 | 0 | 0 |
0.9–0.99 | 1 | 0 | 0 | 0 | 0 | 0 |
1–1.09 | 0 | 0 | 1 | 0 | 0 | 0 |
1.1–1.19 | 0 | 0 | 2 | 0 | 0 | 0 |
1.2–1.29 | 2 | 0 | 1 | 0 | 0 | 0 |
1.3–1.39 | 0 | 0 | 3 | 0 | 0 | 0 |
1.4–1.49 | 2 | 0 | 0 | 1 | 0 | 0 |
1.5–1.59 | 1 | 0 | 0 | 0 | 0 | 0 |
1.6–1.69 | 0 | 0 | 2 | 0 | 0 | 0 |
1.7–1.79 | 1 | 0 | 1 | 1 | 0 | 0 |
1.8–1.89 | 0 | 0 | 0 | 0 | 0 | 0 |
1.9–1.99 | 1 | 0 | 0 | 0 | 0 | 0 |
2–2.99 | 1 | 4 | 5 | 2 | 0 | 0 |
3–3.99 | 1 | 1 | 2 | 0 | 1 | 1 |
4–4.99 | 1 | 1 | 2 | 0 | 0 | 1 |
5–9.99 | 0 | 4 | 5 | 2 | 0 | 0 |
10–19.99 | 0 | 12 | 15 | 19 | 5 | 3 |
20–29.99 | 0 | 24 | 34 | 4 | 3 | 6 |
30–39.99 | 0 | 2 | 4 | 0 | 0 | 1 |
Total | 1059 | 48 | 79 | 29 | 9 | 12 |